Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 27 Apr 2026 for Amicus Therapeutics, INC., €5.7M. Read the official filing
Filing timeline
BuySaleEllen Rosenberg
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Ellen Rosenberg: trading record in brief
All filings by Ellen Rosenberg on record concern Amicus Therapeutics, Inc., in the capacity of senior executive. The record holds 23 filings, for trades running from 31 December 2021 to 27 April 2026.
The open-market record consists of 4 sales worth €696k, with no purchase. Outside the open market, there are 13 share grants and 4 option exercises.
The record was last updated on 27 April 2026 with a transaction (€186k) in Amicus Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ellen Rosenberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
463,898 shares@ US$14.500.14% mcap71.0% of flowCommon StockSEC:0001193125-26-182251:0
15,000 shares@ US$14.500.0047% mcap2.3% of flowCommon StockSEC:0001193125-26-182251:1
13,426 shares@ US$14.277.6% of flowCommon StockSEC:0001193125-26-005049:0
29,683 shares@ US$14.2716.7% of flowCommon StockSEC:0001193125-26-005049:1
25,000 shares@ US$6.101.6% of flowCommon StockSEC:0001193125-25-301017:0
64,800 shares0Common StockSEC:0000950170-25-020018:0
6,442 shares@ US$9.312.7% of flowCommon StockSEC:0000950170-25-002430:0
16,565 shares0Common StockSEC:0000950170-24-032402:0
400 shares@ US$5.160.1% of flowCommon StockSEC:0000950170-24-012843:0
12,000 shares@ US$13.656.9% of flowCommon StockSEC:0000950170-24-004046:0
3,380 shares@ US$13.441.9% of flowCommon StockSEC:0000950170-24-002587:0
30,000 shares@ US$5.166.5% of flowCommon StockSEC:0000950170-24-002111:0
30,000 shares@ US$5.166.5% of flowCommon StockSEC:0000950170-23-073627:0
9,940 shares0Common StockSEC:0000950170-23-071633:0
31,839 shares@ US$13.317218.1% of flowCommon StockSEC:0001209191-23-004863:0
56,024 shares0Common StockSEC:0001209191-23-003307:0
3,575 shares@ US$12.031.9% of flowCommon StockSEC:0001209191-23-002401:0
14,643 shares@ US$12.217.8% of flowCommon StockSEC:0001209191-23-001402:0
11,123 shares@ US$10.02185.0% of flowCommon StockSEC:0001209191-22-044345:0
11,122 shares@ US$10.00470.0023% mcap27.0% of flowCommon StockSEC:0001209191-22-038763:0
11,018 shares@ US$9.05761.1% of flowCommon StockSEC:0001209191-22-023909:0
39,143 sharesCommon StockSEC:0001209191-22-003823:0
9,483 shares@ US$11.551.2% of flowCommon StockSEC:0001209191-22-001214:0
23 of 23 declarations
